Lots of biotech companies today say they want to be great for a long, long time. But which of today’s companies are actually doing it? Which ones are truly visionary, and built to last?
These questions have been on my mind since I re-read “Built to Last: Successful Habits of Visionary Companies” in preparation for an Xconomy event in San Francisco on Dec. 9. The classic book by James C. Collins and Jerry I. Porras came out in 1994. The authors spent six years identifying and studying the common characteristics of companies that had long runs at the top of their industries.
